Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Shares Outstanding (2022 - 2026)

Cannabis Bioscience International Holdings filings provide 5 years of Shares Outstanding readings, the most recent being $11.6 billion for Q1 2026.

  • On a quarterly basis, Shares Outstanding rose 464969.97% to $11.6 billion in Q1 2026 year-over-year; TTM through Feb 2026 was $11.6 billion, a 464969.97% increase, with the full-year FY2025 number at $11.6 billion, up 11.46% from a year prior.
  • Shares Outstanding reached $11.6 billion in Q1 2026 per CBIH's latest filing, up from $2.5 million in the prior quarter.
  • The five-year high for Shares Outstanding was $11.6 billion in Q2 2025, with the low at $2000.0 in Q3 2024.
  • A 5-year average of $5.3 billion and a median of $4.4 billion in 2022 define the central range for Shares Outstanding.
  • Peak annual rise in Shares Outstanding hit 581337367.35% in 2025, while the deepest fall reached 99.98% in 2025.
  • Year by year, Shares Outstanding stood at $8.8 billion in 2022, then grew by 16.78% to $10.3 billion in 2023, then grew by 2.18% to $10.6 billion in 2024, then increased by 10.14% to $11.6 billion in 2025, then changed by 0.0% to $11.6 billion in 2026.
  • Per Business Quant, the three most recent readings for CBIH's Shares Outstanding are $11.6 billion (Q1 2026), $11.6 billion (Q4 2025), and $11.6 billion (Q3 2025).